Patent · US Active

GDF15 fusion proteins and uses thereof

US10336812B2 · kind B2 · utility

7Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2017
Grant dateJul 2, 2019
Priority date
Expiry dateMay 4, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Fusion proteins containing a half-life extension protein, a linker, and a GDF15 protein are described. Also described are nucleic acids encoding the fusion proteins, recombinant cells thereof, compositions comprising the fusion proteins, and methods of using the fusion proteins for treating or preventing metabolic diseases, disorders or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.